PD2/Paf1 depletion in pancreatic acinar cells promotes acinarto-ductal metaplasia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Pancreatic differentiation 2 (PD2), a PAF (RNA Polymerase II Associated Factor) complex subunit, is overexpressed in pancreatic cancer cells and has demonstrated potential oncogenic property. Here, we report that PD2/Paf1 expression was restricted to acinar cells in the normal murine pancreas, but its expression increased in the ductal cells of Pdx1Cre; KrasG12D (KC) mouse model of pancreatic cancer with increasing age, showing highest expression in neoplastic ductal cells of 50 weeks old mice. PD2/Paf1 was specifically expressed in amylase and CK19 double positive metaplastic ducts, representing intermediate structures during pancreatic acinarto-ductal metaplasia (ADM). Similar PD2/Paf1 expression was observed in murine pancreas that exhibited ADM-like histology upon cerulein challenge. In normal mice, cerulein-mediated inflammation induced a decrease in PD2/Paf1 expression, which was later restored upon recovery of the pancreatic parenchyma. In KC mice, however, PD2/Paf1 mRNA level continued to decrease with progressive dysplasia and subsequent neoplastic transformation. Additionally, knockdown of PD2/Paf1 in pancreatic acinar cells resulted in the abrogation of Amylase, Elastase and Lipase (acinar marker) mRNA levels with simultaneous increase in CK19 and CAII (ductal marker) transcripts. In conclusion, our studies indicate loss of PD2/Paf1 expression during acinar transdifferentiation in pancreatic cancer initiation and PD2/Paf1 mediated regulation of lineage specific markers.

Original languageEnglish (US)
Pages (from-to)4480-4491
Number of pages12
JournalOncotarget
Volume5
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Acinar Cells
Metaplasia
Pancreatic Neoplasms
Ceruletide
Amylases
Pancreas
Messenger RNA
RNA Polymerase II
Pancreatic Elastase
Lipase
Histology
Inflammation

Keywords

  • ADM
  • Cerulein
  • PD2/Paf1
  • Pancreatic cancer

ASJC Scopus subject areas

  • Oncology

Cite this

PD2/Paf1 depletion in pancreatic acinar cells promotes acinarto-ductal metaplasia. / Dey, Parama; Rachagani, Satyanarayana; Vaz, Arokia P.; Palanimuthu Ponnusamy, Moorthy; Batra, Surinder Kumar.

In: Oncotarget, Vol. 5, No. 12, 2014, p. 4480-4491.

Research output: Contribution to journalArticle

@article{6276a7fcd1e644fc8ceda07341363f37,
title = "PD2/Paf1 depletion in pancreatic acinar cells promotes acinarto-ductal metaplasia",
abstract = "Pancreatic differentiation 2 (PD2), a PAF (RNA Polymerase II Associated Factor) complex subunit, is overexpressed in pancreatic cancer cells and has demonstrated potential oncogenic property. Here, we report that PD2/Paf1 expression was restricted to acinar cells in the normal murine pancreas, but its expression increased in the ductal cells of Pdx1Cre; KrasG12D (KC) mouse model of pancreatic cancer with increasing age, showing highest expression in neoplastic ductal cells of 50 weeks old mice. PD2/Paf1 was specifically expressed in amylase and CK19 double positive metaplastic ducts, representing intermediate structures during pancreatic acinarto-ductal metaplasia (ADM). Similar PD2/Paf1 expression was observed in murine pancreas that exhibited ADM-like histology upon cerulein challenge. In normal mice, cerulein-mediated inflammation induced a decrease in PD2/Paf1 expression, which was later restored upon recovery of the pancreatic parenchyma. In KC mice, however, PD2/Paf1 mRNA level continued to decrease with progressive dysplasia and subsequent neoplastic transformation. Additionally, knockdown of PD2/Paf1 in pancreatic acinar cells resulted in the abrogation of Amylase, Elastase and Lipase (acinar marker) mRNA levels with simultaneous increase in CK19 and CAII (ductal marker) transcripts. In conclusion, our studies indicate loss of PD2/Paf1 expression during acinar transdifferentiation in pancreatic cancer initiation and PD2/Paf1 mediated regulation of lineage specific markers.",
keywords = "ADM, Cerulein, PD2/Paf1, Pancreatic cancer",
author = "Parama Dey and Satyanarayana Rachagani and Vaz, {Arokia P.} and {Palanimuthu Ponnusamy}, Moorthy and Batra, {Surinder Kumar}",
year = "2014",
doi = "10.18632/oncotarget.2041",
language = "English (US)",
volume = "5",
pages = "4480--4491",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "12",

}

TY - JOUR

T1 - PD2/Paf1 depletion in pancreatic acinar cells promotes acinarto-ductal metaplasia

AU - Dey, Parama

AU - Rachagani, Satyanarayana

AU - Vaz, Arokia P.

AU - Palanimuthu Ponnusamy, Moorthy

AU - Batra, Surinder Kumar

PY - 2014

Y1 - 2014

N2 - Pancreatic differentiation 2 (PD2), a PAF (RNA Polymerase II Associated Factor) complex subunit, is overexpressed in pancreatic cancer cells and has demonstrated potential oncogenic property. Here, we report that PD2/Paf1 expression was restricted to acinar cells in the normal murine pancreas, but its expression increased in the ductal cells of Pdx1Cre; KrasG12D (KC) mouse model of pancreatic cancer with increasing age, showing highest expression in neoplastic ductal cells of 50 weeks old mice. PD2/Paf1 was specifically expressed in amylase and CK19 double positive metaplastic ducts, representing intermediate structures during pancreatic acinarto-ductal metaplasia (ADM). Similar PD2/Paf1 expression was observed in murine pancreas that exhibited ADM-like histology upon cerulein challenge. In normal mice, cerulein-mediated inflammation induced a decrease in PD2/Paf1 expression, which was later restored upon recovery of the pancreatic parenchyma. In KC mice, however, PD2/Paf1 mRNA level continued to decrease with progressive dysplasia and subsequent neoplastic transformation. Additionally, knockdown of PD2/Paf1 in pancreatic acinar cells resulted in the abrogation of Amylase, Elastase and Lipase (acinar marker) mRNA levels with simultaneous increase in CK19 and CAII (ductal marker) transcripts. In conclusion, our studies indicate loss of PD2/Paf1 expression during acinar transdifferentiation in pancreatic cancer initiation and PD2/Paf1 mediated regulation of lineage specific markers.

AB - Pancreatic differentiation 2 (PD2), a PAF (RNA Polymerase II Associated Factor) complex subunit, is overexpressed in pancreatic cancer cells and has demonstrated potential oncogenic property. Here, we report that PD2/Paf1 expression was restricted to acinar cells in the normal murine pancreas, but its expression increased in the ductal cells of Pdx1Cre; KrasG12D (KC) mouse model of pancreatic cancer with increasing age, showing highest expression in neoplastic ductal cells of 50 weeks old mice. PD2/Paf1 was specifically expressed in amylase and CK19 double positive metaplastic ducts, representing intermediate structures during pancreatic acinarto-ductal metaplasia (ADM). Similar PD2/Paf1 expression was observed in murine pancreas that exhibited ADM-like histology upon cerulein challenge. In normal mice, cerulein-mediated inflammation induced a decrease in PD2/Paf1 expression, which was later restored upon recovery of the pancreatic parenchyma. In KC mice, however, PD2/Paf1 mRNA level continued to decrease with progressive dysplasia and subsequent neoplastic transformation. Additionally, knockdown of PD2/Paf1 in pancreatic acinar cells resulted in the abrogation of Amylase, Elastase and Lipase (acinar marker) mRNA levels with simultaneous increase in CK19 and CAII (ductal marker) transcripts. In conclusion, our studies indicate loss of PD2/Paf1 expression during acinar transdifferentiation in pancreatic cancer initiation and PD2/Paf1 mediated regulation of lineage specific markers.

KW - ADM

KW - Cerulein

KW - PD2/Paf1

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84905115221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905115221&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.2041

DO - 10.18632/oncotarget.2041

M3 - Article

C2 - 24947474

AN - SCOPUS:84905115221

VL - 5

SP - 4480

EP - 4491

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 12

ER -